In silico analysis of IL7RA missense mutations in lung, breast and skin cancers

Interleukin 7 (IL7)-Interleukin 7 Receptor Alpha (IL7RA) signaling is well investigated in hematological cancers, but in solid cancers, its role needs to be investigated further. In a recent study, IL7R was identified as a key gene in leptomeningeal carcinoma. Unfortunately, there is limited patient...

Full description

Saved in:
Bibliographic Details
Main Author: Zeynep Tokcaer Keskin
Format: Article
Language:English
Published: Trakya University 2025-04-01
Series:Trakya University Journal of Natural Sciences
Subjects:
Online Access:https://dergipark.org.tr/en/download/article-file/4199691
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850174928807002112
author Zeynep Tokcaer Keskin
author_facet Zeynep Tokcaer Keskin
author_sort Zeynep Tokcaer Keskin
collection DOAJ
description Interleukin 7 (IL7)-Interleukin 7 Receptor Alpha (IL7RA) signaling is well investigated in hematological cancers, but in solid cancers, its role needs to be investigated further. In a recent study, IL7R was identified as a key gene in leptomeningeal carcinoma. Unfortunately, there is limited patient data on leptomeningeal carcinoma from breast, lung and skin cancers. In this study, IL7RA missense mutations that could have pathologic importance in lung, breast and skin cancers were analyzed in silico. Using Genomic Data Commons (GDC) data portal, lung, breast and melanoma data from 3250 patients were filtered to list IL7RA missense mutations. Sorting Intolerant From Tolerant (SIFT), Polymorphism Phenotyping v2 (PolyPhen2), Universal Mutation Database Predictor (UMD-Predictor) and Single Nucleotide Polymorphisms & Gene Ontology (E-SNP&GO) servers were employed to reveal pathogenic variants. Conservation Surface Mapping (ConSurf )was used to analyze conservation scores. Domains were investigated by InterPro tool. Molecular docking of IL7-IL7RA was performed by ClusPro, Mutational Binding free energy change predictor 2 (Mutabind2) and Protein-Ligand Interaction Profiler (PLIP) servers. Stability of the mutations were analyzed by Impact-Mutant 2.0 (I-Mutant2), Mutation Protein Stability Prediction (MUpro) and Impact of Non-synonymous mutations on Protein Stability-Multi Dimension (INPS-MD). Structural changes were determined using Dynamic Mutation predictor 2 (DynaMut2) and Have (y)Our Protein Explained (HOPE) servers. Out of 99 missense mutations identified, 6 (T56P, C57Y, K204I, S207F, G215V and W217C) were defined as pathogenic. All these mutations were primarily found in lung cancer and located in the extracellular domain of IL7RA. Although none were in the interaction interface of IL7, all were located at or next to conserved motifs. This proximity likely destabilizes IL7RA and drastically changes its bonding patterns. The IL7RA missense mutations may have a significant role in lung cancer, as they presumably change the protein’s function.
format Article
id doaj-art-57236f9d049c4c0f86d093e0916a57f4
institution OA Journals
issn 2528-9691
language English
publishDate 2025-04-01
publisher Trakya University
record_format Article
series Trakya University Journal of Natural Sciences
spelling doaj-art-57236f9d049c4c0f86d093e0916a57f42025-08-20T02:19:34ZengTrakya UniversityTrakya University Journal of Natural Sciences2528-96912025-04-0126191710.23902/trkjnat.154567869In silico analysis of IL7RA missense mutations in lung, breast and skin cancersZeynep Tokcaer Keskin0https://orcid.org/0000-0001-7678-0590ACIBADEM MEHMET ALİ AYDINLAR ÜNİVERSİTESİInterleukin 7 (IL7)-Interleukin 7 Receptor Alpha (IL7RA) signaling is well investigated in hematological cancers, but in solid cancers, its role needs to be investigated further. In a recent study, IL7R was identified as a key gene in leptomeningeal carcinoma. Unfortunately, there is limited patient data on leptomeningeal carcinoma from breast, lung and skin cancers. In this study, IL7RA missense mutations that could have pathologic importance in lung, breast and skin cancers were analyzed in silico. Using Genomic Data Commons (GDC) data portal, lung, breast and melanoma data from 3250 patients were filtered to list IL7RA missense mutations. Sorting Intolerant From Tolerant (SIFT), Polymorphism Phenotyping v2 (PolyPhen2), Universal Mutation Database Predictor (UMD-Predictor) and Single Nucleotide Polymorphisms & Gene Ontology (E-SNP&GO) servers were employed to reveal pathogenic variants. Conservation Surface Mapping (ConSurf )was used to analyze conservation scores. Domains were investigated by InterPro tool. Molecular docking of IL7-IL7RA was performed by ClusPro, Mutational Binding free energy change predictor 2 (Mutabind2) and Protein-Ligand Interaction Profiler (PLIP) servers. Stability of the mutations were analyzed by Impact-Mutant 2.0 (I-Mutant2), Mutation Protein Stability Prediction (MUpro) and Impact of Non-synonymous mutations on Protein Stability-Multi Dimension (INPS-MD). Structural changes were determined using Dynamic Mutation predictor 2 (DynaMut2) and Have (y)Our Protein Explained (HOPE) servers. Out of 99 missense mutations identified, 6 (T56P, C57Y, K204I, S207F, G215V and W217C) were defined as pathogenic. All these mutations were primarily found in lung cancer and located in the extracellular domain of IL7RA. Although none were in the interaction interface of IL7, all were located at or next to conserved motifs. This proximity likely destabilizes IL7RA and drastically changes its bonding patterns. The IL7RA missense mutations may have a significant role in lung cancer, as they presumably change the protein’s function.https://dergipark.org.tr/en/download/article-file/4199691interlekin 7 receptor alphamissense mutationlung cancercomputational biologyin silico simulation
spellingShingle Zeynep Tokcaer Keskin
In silico analysis of IL7RA missense mutations in lung, breast and skin cancers
Trakya University Journal of Natural Sciences
interlekin 7 receptor alpha
missense mutation
lung cancer
computational biology
in silico simulation
title In silico analysis of IL7RA missense mutations in lung, breast and skin cancers
title_full In silico analysis of IL7RA missense mutations in lung, breast and skin cancers
title_fullStr In silico analysis of IL7RA missense mutations in lung, breast and skin cancers
title_full_unstemmed In silico analysis of IL7RA missense mutations in lung, breast and skin cancers
title_short In silico analysis of IL7RA missense mutations in lung, breast and skin cancers
title_sort in silico analysis of il7ra missense mutations in lung breast and skin cancers
topic interlekin 7 receptor alpha
missense mutation
lung cancer
computational biology
in silico simulation
url https://dergipark.org.tr/en/download/article-file/4199691
work_keys_str_mv AT zeyneptokcaerkeskin insilicoanalysisofil7ramissensemutationsinlungbreastandskincancers